Degradation of α-actin filaments in venous smooth muscle cells in response to mechanical stretch

Jeremy Goldman*, Lin Zhong, Shu Q. Liu

*Corresponding author for this work

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Mechanical stretch has been shown to induce the degradation of α-actin filaments in smooth muscle cells (SMC) of experimental vein grafts. Here, we investigate the possible role of ERK1/2 and p38 MAPK in regulating this process using an ex vivo venous culture model that simulates an experimental vein graft. An exposure of a vein to arterial pressure induced a significant increase in the medial circumferential strain, which induced rapid α-actin filament disruption, followed by degradation. The percentage of SMC α-actin filament coverage was reduced significantly under arterial pressure (91 ± 1%, 43 ± 13%, 51 ± 5%, 28 ± 3%, and 19 ± 5% at 1, 6, 12, 24, and 48 h, respectively), whereas it did not change significantly in specimens under venous pressure at theses times. The degradation of SMC α-actin filaments paralleled an increase in the relative activity of caspase 3 (3.0 ± 0.7- and 1.7 ± 0.4-fold increase relative to the control level at 6 and 12 h, respectively) and a decrease in SMC density (from the control level of 1,368 ± 66 cells/mm2 at time 0 to 1,205 ± 90, 783 ± 129, 845 ± 61, 637 ± 55, and 432 ± 125 cells/mm2 at 1, 6, 12, 24, and 48 h of exposure to arterial pressure, respectively). Treatment with a p38 MAPK inhibitor (SB-203580) significantly reduced the stretch-induced activation of caspase 3 at 6 h (from 3.0 ± 0.7- to 2.2 ± 0.3-fold) in conjunction with a significant rescue of α-actin filament degradation (from 43 ± 13% to 69 ± 15%) at the same time. Treatment with an inhibitor for the ERK1/2 activator (PD-98059), however, did not induce a significant change in the activity of caspase 3 or the percentage of SMC α-actin filament coverage. These results suggest that p38 MAPK and caspase 3 may mediate stretch-dependent degradation of α-actin filaments in vascular SMCs.

Original languageEnglish (US)
Pages (from-to)H1839-H1847
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume284
Issue number5 53-5
StatePublished - May 1 2003

Fingerprint

Actin Cytoskeleton
Smooth Muscle Myocytes
Caspase 3
p38 Mitogen-Activated Protein Kinases
Veins
Arterial Pressure
Transplants
Venous Pressure
Blood Vessels
Theoretical Models
Cell Count

Keywords

  • Caspase 3
  • Mitogen-activated protein kinases
  • Vascular grafts

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{ec4d01659613476397dbc22cc0360853,
title = "Degradation of α-actin filaments in venous smooth muscle cells in response to mechanical stretch",
abstract = "Mechanical stretch has been shown to induce the degradation of α-actin filaments in smooth muscle cells (SMC) of experimental vein grafts. Here, we investigate the possible role of ERK1/2 and p38 MAPK in regulating this process using an ex vivo venous culture model that simulates an experimental vein graft. An exposure of a vein to arterial pressure induced a significant increase in the medial circumferential strain, which induced rapid α-actin filament disruption, followed by degradation. The percentage of SMC α-actin filament coverage was reduced significantly under arterial pressure (91 ± 1{\%}, 43 ± 13{\%}, 51 ± 5{\%}, 28 ± 3{\%}, and 19 ± 5{\%} at 1, 6, 12, 24, and 48 h, respectively), whereas it did not change significantly in specimens under venous pressure at theses times. The degradation of SMC α-actin filaments paralleled an increase in the relative activity of caspase 3 (3.0 ± 0.7- and 1.7 ± 0.4-fold increase relative to the control level at 6 and 12 h, respectively) and a decrease in SMC density (from the control level of 1,368 ± 66 cells/mm2 at time 0 to 1,205 ± 90, 783 ± 129, 845 ± 61, 637 ± 55, and 432 ± 125 cells/mm2 at 1, 6, 12, 24, and 48 h of exposure to arterial pressure, respectively). Treatment with a p38 MAPK inhibitor (SB-203580) significantly reduced the stretch-induced activation of caspase 3 at 6 h (from 3.0 ± 0.7- to 2.2 ± 0.3-fold) in conjunction with a significant rescue of α-actin filament degradation (from 43 ± 13{\%} to 69 ± 15{\%}) at the same time. Treatment with an inhibitor for the ERK1/2 activator (PD-98059), however, did not induce a significant change in the activity of caspase 3 or the percentage of SMC α-actin filament coverage. These results suggest that p38 MAPK and caspase 3 may mediate stretch-dependent degradation of α-actin filaments in vascular SMCs.",
keywords = "Caspase 3, Mitogen-activated protein kinases, Vascular grafts",
author = "Jeremy Goldman and Lin Zhong and Liu, {Shu Q.}",
year = "2003",
month = "5",
day = "1",
language = "English (US)",
volume = "284",
pages = "H1839--H1847",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 53-5",

}

Degradation of α-actin filaments in venous smooth muscle cells in response to mechanical stretch. / Goldman, Jeremy; Zhong, Lin; Liu, Shu Q.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 284, No. 5 53-5, 01.05.2003, p. H1839-H1847.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Degradation of α-actin filaments in venous smooth muscle cells in response to mechanical stretch

AU - Goldman, Jeremy

AU - Zhong, Lin

AU - Liu, Shu Q.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Mechanical stretch has been shown to induce the degradation of α-actin filaments in smooth muscle cells (SMC) of experimental vein grafts. Here, we investigate the possible role of ERK1/2 and p38 MAPK in regulating this process using an ex vivo venous culture model that simulates an experimental vein graft. An exposure of a vein to arterial pressure induced a significant increase in the medial circumferential strain, which induced rapid α-actin filament disruption, followed by degradation. The percentage of SMC α-actin filament coverage was reduced significantly under arterial pressure (91 ± 1%, 43 ± 13%, 51 ± 5%, 28 ± 3%, and 19 ± 5% at 1, 6, 12, 24, and 48 h, respectively), whereas it did not change significantly in specimens under venous pressure at theses times. The degradation of SMC α-actin filaments paralleled an increase in the relative activity of caspase 3 (3.0 ± 0.7- and 1.7 ± 0.4-fold increase relative to the control level at 6 and 12 h, respectively) and a decrease in SMC density (from the control level of 1,368 ± 66 cells/mm2 at time 0 to 1,205 ± 90, 783 ± 129, 845 ± 61, 637 ± 55, and 432 ± 125 cells/mm2 at 1, 6, 12, 24, and 48 h of exposure to arterial pressure, respectively). Treatment with a p38 MAPK inhibitor (SB-203580) significantly reduced the stretch-induced activation of caspase 3 at 6 h (from 3.0 ± 0.7- to 2.2 ± 0.3-fold) in conjunction with a significant rescue of α-actin filament degradation (from 43 ± 13% to 69 ± 15%) at the same time. Treatment with an inhibitor for the ERK1/2 activator (PD-98059), however, did not induce a significant change in the activity of caspase 3 or the percentage of SMC α-actin filament coverage. These results suggest that p38 MAPK and caspase 3 may mediate stretch-dependent degradation of α-actin filaments in vascular SMCs.

AB - Mechanical stretch has been shown to induce the degradation of α-actin filaments in smooth muscle cells (SMC) of experimental vein grafts. Here, we investigate the possible role of ERK1/2 and p38 MAPK in regulating this process using an ex vivo venous culture model that simulates an experimental vein graft. An exposure of a vein to arterial pressure induced a significant increase in the medial circumferential strain, which induced rapid α-actin filament disruption, followed by degradation. The percentage of SMC α-actin filament coverage was reduced significantly under arterial pressure (91 ± 1%, 43 ± 13%, 51 ± 5%, 28 ± 3%, and 19 ± 5% at 1, 6, 12, 24, and 48 h, respectively), whereas it did not change significantly in specimens under venous pressure at theses times. The degradation of SMC α-actin filaments paralleled an increase in the relative activity of caspase 3 (3.0 ± 0.7- and 1.7 ± 0.4-fold increase relative to the control level at 6 and 12 h, respectively) and a decrease in SMC density (from the control level of 1,368 ± 66 cells/mm2 at time 0 to 1,205 ± 90, 783 ± 129, 845 ± 61, 637 ± 55, and 432 ± 125 cells/mm2 at 1, 6, 12, 24, and 48 h of exposure to arterial pressure, respectively). Treatment with a p38 MAPK inhibitor (SB-203580) significantly reduced the stretch-induced activation of caspase 3 at 6 h (from 3.0 ± 0.7- to 2.2 ± 0.3-fold) in conjunction with a significant rescue of α-actin filament degradation (from 43 ± 13% to 69 ± 15%) at the same time. Treatment with an inhibitor for the ERK1/2 activator (PD-98059), however, did not induce a significant change in the activity of caspase 3 or the percentage of SMC α-actin filament coverage. These results suggest that p38 MAPK and caspase 3 may mediate stretch-dependent degradation of α-actin filaments in vascular SMCs.

KW - Caspase 3

KW - Mitogen-activated protein kinases

KW - Vascular grafts

UR - http://www.scopus.com/inward/record.url?scp=0037404455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037404455&partnerID=8YFLogxK

M3 - Article

C2 - 12531720

AN - SCOPUS:0037404455

VL - 284

SP - H1839-H1847

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 5 53-5

ER -